Your browser is no longer supported. Please, upgrade your browser.
TEVA Teva Pharmaceutical Industries Limited monthly Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-3.42 Insider Own2.70% Shs Outstand1.09B Perf Week-3.33%
Market Cap12.02B Forward P/E4.28 EPS next Y2.58 Insider Trans-0.19% Shs Float1.05B Perf Month-26.40%
Income-3523.00M PEG- EPS next Q0.58 Inst Own62.30% Short Float1.74% Perf Quarter-36.00%
Sales18.08B P/S0.66 EPS this Y87.00% Inst Trans-1.77% Short Ratio1.47 Perf Half Y-49.82%
Book/sh13.52 P/B0.82 EPS next Y8.41% ROA-5.60% Target Price18.67 Perf Year-47.43%
Cash/sh1.81 P/C6.09 EPS next 5Y-1.07% ROE-24.70% 52W Range11.26 - 25.96 Perf YTD-28.40%
Dividend- P/FCF26.76 EPS past 5Y-28.50% ROI-3.20% 52W High-57.47% Beta1.40
Dividend %- Quick Ratio0.60 Sales past 5Y-1.50% Gross Margin43.10% 52W Low-1.95% ATR0.58
Employees42535 Current Ratio1.00 Sales Q/Q-15.20% Oper. Margin-16.70% RSI (14)22.19 Volatility3.98% 3.84%
OptionableYes Debt/Eq1.94 EPS Q/Q-114.70% Profit Margin-19.70% Rel Volume1.22 Prev Close11.54
ShortableYes LT Debt/Eq1.75 EarningsMay 02 BMO Payout- Avg Volume12.37M Price11.04
Recom2.80 SMA20-19.20% SMA50-25.10% SMA200-41.74% Volume15,128,537 Change-4.33%
Mar-20-19Initiated SunTrust Hold
Mar-07-19Resumed UBS Buy $22
Mar-06-19Downgrade Morgan Stanley Overweight → Equal-Weight $17
Feb-20-19Downgrade Mizuho Buy → Neutral $25 → $18
Feb-14-19Upgrade Raymond James Mkt Perform → Outperform $22
Jan-23-19Upgrade UBS Neutral → Buy
Jan-23-19Upgrade Piper Jaffray Underweight → Neutral
Jan-03-19Upgrade BofA/Merrill Underperform → Buy
Nov-05-18Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-01-18Upgrade Leerink Partners Underperform → Mkt Perform
Sep-21-18Resumed Oppenheimer Perform
Sep-17-18Upgrade BTIG Research Sell → Neutral
Sep-07-18Downgrade Credit Suisse Outperform → Neutral
Jun-27-18Reiterated Citigroup Buy $25 → $27
Mar-20-18Resumed Jefferies Hold $19
Feb-12-18Upgrade Credit Suisse Neutral → Outperform
Feb-09-18Upgrade RBC Capital Mkts Underperform → Sector Perform
Feb-09-18Downgrade Piper Jaffray Neutral → Underweight
Feb-09-18Downgrade Gabelli & Co Buy → Hold
Feb-02-18Downgrade BTIG Research Neutral → Sell $17
May-23-19 12:07PM  This May Hurt a Little (Or a Lot) as Opioids Haunt Pharma Bonds Bloomberg
May-22-19 08:49AM  Better Turnaround Play: Bausch Health Companies or Teva Pharmaceutical Industries Motley Fool
May-20-19 04:05PM  TEVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Teva Pharmaceutical Industries Limited To Contact The Firm ACCESSWIRE
12:04PM  Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock InvestorPlace
May-18-19 11:44AM  Warren Buffett Stocks Fall: Teva Pharmaceutical Up 1.8%; StoneCo Off 3.7% TheStreet.com
May-17-19 05:19PM  Roche Gets FDA Nod for Venclexta Plus Gazyva to Treat CLL Zacks
May-16-19 04:07PM  6 Positions the Vanguard Health Care Fund Continues to Increase GuruFocus.com
08:00AM  Generic Drugs Are Stabilizing Can They Survive An Antitrust Scandal? Investor's Business Daily
May-15-19 11:47AM  Teva Hits Fibonacci Support on Concerns Over Lawsuit Investopedia -5.45%
10:30AM  Mylan's stock falls toward 7 1/2-year low; credit rating now in danger of downgrade to 'junk' at Fitch MarketWatch
09:24AM  The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer Zacks
May-14-19 12:50PM  Options Traders Making Big Long-Term Bets On Teva Benzinga
10:18AM  Company News For May 14, 2019 Zacks
09:56AM  The Zacks Analyst Blog Highlights: Teva, Amazon, Berkshire and JPMorgan Zacks
09:18AM  Generic Drugmakers Face Antitrust Suit Alleging Price Fixing Zacks
May-13-19 05:49PM  TEVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Teva Pharmaceutical Industries Limited To Contact The Firm PR Newswire -14.83%
05:46PM  States Expand Suit Against Teva & Others, Shares Plunge Zacks
05:38PM  Generic Drug Makers: The Largest 'Cartel' In U.S. History? Investor's Business Daily
05:06PM  What Happened in the Stock Market Today Motley Fool
04:35PM  Teva and Apple fall while Newmont Goldcorp and NextEra rise Associated Press
04:08PM  Dow Ends Sharply Lower; Trade War Escalation Slams Stocks TheStreet.com
03:42PM  5 Top Stock Trades for Tuesday: Amazon, Teva, S&P 500 InvestorPlace
02:47PM  Teva Stock Is Sinking as a Lawsuit Alleges a Drug-Pricing Conspiracy Barrons.com
02:33PM  How Low Can Teva Pharmaceutical Stock Go? Don't Fight the Tape TheStreet.com
02:02PM  Why Teva Pharmaceutical Is Getting Hammered Today Motley Fool
01:23PM  Teva Falls as Drugmakers Alleged to Have Artificially Inflated Prices TheStreet.com
01:06PM  Stocks making the biggest moves midday: Teva Pharmaceutical, Boeing, Uber & more CNBC
12:42PM  Forty-four states accuse Teva Pharmaceutical of inflating drug prices CNBC Videos
12:35PM  Endo Pharmaceutical Falls After Downgrade to Underweight at JPMorgan TheStreet.com
12:26PM  Teva Pharmaceutical drops 16% after 44 states accuse drugmaker of conspiring to hike generic drug prices CNBC
11:56AM  The Late Morning Rundown: May 13, 2019 CNBC Videos
10:43AM  Teva Pharmaceutical Put Volume Pops on Lawsuit Woes Schaeffer's Investment Research
08:40AM  Teva Plummets Amid Massive Price Fixing Accusations; Other Generic Drugmakers Also Fall Benzinga
07:57AM  Stocks making the biggest moves premarket: Disney, Teva Pharmaceuticals, Uber, Pinterest & more CNBC
06:26AM  Stock Selloff, Trade War, Teva, Take-Two and Oil Prices - 5 Things You Must Know TheStreet.com
04:18AM  Stocks - FAANGs Slide in Premarket, Teva Sinks, Uber Extends Losses Investing.com
May-12-19 09:01AM  Teva Pharm CFO says company did not conspire to fix prices Reuters
07:58AM  Teva Pharm CFO says company did not conspire to fix prices Reuters
May-11-19 09:42PM  U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit Reuters
12:50PM  U.S. states accuse Teva, other drugmakers, of price-fixing - lawsuit Reuters
12:00PM  U.S. states accuse Teva, other drugmakers, of price-fixing -lawsuit Reuters
10:31AM  Teva, other drug companies accused in sweeping U.S. price-fixing scheme - lawsuit Reuters
09:46AM  U.S. states sue Teva, 19 other drug companies in price-fixing complaint Reuters
May-10-19 03:50PM  Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions Reuters
03:10PM  Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions Reuters
11:56AM  Corcept Therapeutics Incorporated (CORT) Q1 2019 Earnings Call Transcript Motley Fool
11:51AM  Teva Announces the Launch of a Generic Version of Delzicol® (mesalamine) Delayed-Release Capsules in the United States Business Wire
08:00AM  The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma's Weak Breast Cancer Drug Sales Benzinga
May-09-19 04:06PM  Teva Announces Launch of a Generic Version of Tarceva® (erlotinib) Tablets in the United States Business Wire
May-07-19 03:41PM  Momenta Pharmaceuticals Wants to Be the "Humira of the FcRn Space" Motley Fool
01:51PM  Mylan's (MYL) Q1 Earnings Beat Estimates, Revenues Miss Zacks
12:23PM  Eagle Pharmaceuticals Inc (EGRX) Q1 2019 Earnings Call Transcript Motley Fool
09:40AM  BioDelivery (BDSI) Stock Up on Q1 Earnings and Sales Beat Zacks
09:27AM  Allergan (AGN) Beats on Q1 Earnings & Sales, Raises '19 View Zacks
08:58AM  Mylan shares down 4.5% after drugmaker misses on revenue MarketWatch
May-06-19 07:51AM  Buffett's Berkshire Has Been Buying Amazon Stock, but There's a Big Catch Motley Fool
May-05-19 07:00AM  Why Are Investors Passing on Teva Pharmaceutical Industries? Motley Fool
May-03-19 05:22PM  Mylan (MYL) to Report Q1 Earnings: What's in the Offing? Zacks
02:46PM  6 "Warren Buffett Stocks" That Might Not Be His Ideas Kiplinger
08:00AM  Teva to Present New Long-Term Data on Efficacy and Safety of Fremanezumab at 2019 American Academy of Neurology Annual Meeting Business Wire
06:28AM  Teva (TEVA) Q1 Earnings Beat, Copaxone Drags Sales Down Zacks
May-02-19 04:08PM  These 2 Drug Giants Beat Earnings Views; But Only One Entered Buy Range Investor's Business Daily
02:28PM  Declining sales of blockbuster drug drag Teva revenue lower MarketWatch
01:51PM  The Vanguard Health Care Fund's Top 5 Buys of the 1st Quarter GuruFocus.com
01:48PM  Teva Pharmaceutical Industries Limited (TEVA) Q1 2019 Earnings Call Transcript Motley Fool
01:44PM  Teva's new migraine drug helps to contain profit fall Reuters
01:02PM  Teva Pharmaceuticals CEO: Stock on Track for 2020 Turnaround TheStreet.com
09:49AM  Teva Falls as Sales of Copaxone Decline Faster Than Expected Bloomberg
08:45AM  Teva (TEVA) Beats on Q1 Earnings, Misses Sales, Shares Down Zacks
07:44AM  Israel's Teva Pharm Q1 profit falls slightly less than forecast Reuters
07:28AM  Teva stock up 2% after company beats on earnings but misses on revenue MarketWatch
07:08AM  Israel's Teva Pharm Q1 profit falls slightly less than forecast Reuters
07:00AM  Teva Reports First Quarter 2019 Financial Results Business Wire
01:02AM  Teva boss hits out at opioid lawsuits Financial Times
May-01-19 03:01PM  Teva Announces Launch of a Generic Version of Letairis® (ambrisentan) Tablets in the United States Business Wire
08:00AM  Teva to Present New Central Nervous System Portfolio Data at 71st Annual Meeting of the American Academy of Neurology Business Wire
Apr-30-19 11:31AM  Lilly (LLY) Down Despite Q1 Earnings Beat on Sales View Cut Zacks
11:21AM  Eli Lilly slashes guidance in face of pricing pressures and growing generic competition MarketWatch
06:45AM  3 Warren Buffett Stocks Worth Buying Now Motley Fool
Apr-29-19 04:10PM  Insulin-maker Eli Lilly is scheduled to report earnings Tuesday. Heres what to expect MarketWatch
12:23PM  The obscure advisory committees at the heart of the U.S. drug pricing debate Reuters
12:15PM  The obscure advisory committees at the heart of the U.S. drug pricing debate Reuters
09:43AM  Teva (TEVA) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-27-19 06:00PM  3 Top Healthcare Stocks to Buy Right Now Motley Fool
Apr-26-19 08:02AM  The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug Benzinga
Apr-25-19 05:50PM  Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know Zacks
Apr-23-19 10:59AM  Amgen (AMGN) to Report Q1 Earnings: What's in the Cards? Zacks
10:33AM  Teva stops testing its migraine drug as cluster headache treatment Reuters
09:13AM  Teva to stop developing cluster headache treatment Reuters
09:00AM  Teva Announces Update on Fremanezumab Clinical Development for use in Episodic Cluster Headache Business Wire
Apr-22-19 11:03AM  Teva Announces Launch of a Generic Version of VESIcare® (solifenacin succinate) Tablets in the United States Business Wire
Apr-19-19 01:58PM  U.S. FDA approves Teva's generic nasal spray to treat opioid overdose Reuters
12:04PM  FDA approves first generic naloxone nasal spray to treat opioid overdose MarketWatch
Apr-16-19 11:41AM  Allergan Falls as Supreme Court Dismisses Restasis Litigation Zacks
Apr-11-19 10:00AM  Teva Announces Launch of a Generic Version of AndroGel® (testosterone gel) 1.62% CIII in the United States Business Wire
09:34AM  BioDelivery (BDSI) Buys US Rights to Pain Drug for $30M Zacks
08:26AM  9 High-Risk Stocks to Buy for Massive Rewards InvestorPlace
Apr-10-19 08:00AM  Teva Signs New $2.3 Billion Syndicated Revolving Credit Facility Business Wire
Apr-08-19 05:00PM  Teva to Host Conference Call to Discuss First Quarter 2019 Financial Results at 8 a.m. ET on May 2, 2019 Business Wire
09:41AM  The Zacks Analyst Blog Highlights: Pfizer, Teva, Novartis, Merck and AstraZeneca Zacks
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
de Notaristefani CarloExecutive VP Global OperationsMay 20Sale11.4216,070183,51933,589May 21 06:38 AM
de Notaristefani CarloExecutive VP Global OperationsMay 16Sale11.766297,39718,784May 20 07:18 AM
O'Grady Brendan P.EVP, North America CommercialMar 18Sale16.631,17919,6011,388Mar 19 08:29 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 18Sale16.643205,3269,002Mar 19 08:17 AM
Daniell RichardExec. VP, European CommercialMar 18Sale16.641,29721,5880Mar 19 08:14 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 18Sale16.432,35838,7422,974Mar 19 08:11 AM
McClellan Michael JamesEVP, Chief Financial OfficerMar 18Sale16.632303,82412,760Mar 19 08:08 AM
Griffin Deborah AChief Accounting OfficerMar 18Sale16.6394315,6770Mar 19 08:06 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 18Sale16.633565,91916,750Mar 19 08:04 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 18Sale16.6363210,5079,149Mar 19 08:02 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 12Sale15.822,44438,6642,974Mar 14 07:44 AM
O'Grady Brendan P.EVP, North America CommercialMar 12Sale15.6773811,5681,388Mar 14 07:41 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 12Sale15.693255,0998,450Mar 14 07:36 AM
Griffin Deborah AChief Accounting OfficerMar 12Sale15.6795314,9380Mar 14 07:33 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 12Sale15.6764710,1428,602Mar 14 07:31 AM
Daniell RichardExec. VP, European CommercialMar 12Sale15.6971511,2180Mar 14 07:28 AM
O'Grady Brendan P.EVP, North America CommercialMar 04Sale16.881,16619,6861,388Mar 05 07:36 AM
McClellan Michael JamesEVP, Chief Financial OfficerMar 04Sale16.883636,12912,330Mar 05 07:28 AM
Griffin Deborah AChief Accounting OfficerMar 04Sale16.884,10769,3400Mar 05 07:23 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 04Sale16.884096,90516,094Mar 05 07:16 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 04Sale16.8860610,2318,058Mar 05 07:10 AM
Daniell RichardExec. VP, European CommercialMar 04Sale16.882,09835,4230Mar 05 07:05 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 04Sale16.885128,6457,892Mar 05 08:20 AM
Stark David MatthewExec. VP Chief Legal OfficerFeb 14Sale17.743,92669,6472,974Feb 19 07:26 AM
de Notaristefani CarloExecutive VP Global OperationsFeb 14Sale17.673,19256,39918,209Feb 19 07:05 AM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 14Sale17.671,84132,52915,338Feb 19 07:11 AM
de Notaristefani CarloExecutive VP Global OperationsFeb 13Sale17.885,04190,10812,121Feb 14 07:43 AM
Fridriksdottir HafrunExecutive VP, Global R&DJan 02Sale15.701,64325,79911,826Jan 03 07:24 AM
Fridriksdottir HafrunExecutive VP, Global R&DNov 30Sale21.7693320,3048,829Dec 04 08:09 AM
McClellan Michael JamesEVP, Chief Financial OfficerNov 05Sale22.733467,86511,644Nov 07 06:38 AM
Daniell RichardExec. VP, European CommercialSep 18Sale23.692,48858,9430Sep 20 04:04 PM
O'Grady Brendan P.EVP, North America CommercialSep 18Sale23.711,24129,4201,388Sep 20 04:10 PM
Nazzi GianfrancoEVP, Growth Markets CommercialSep 18Sale23.691,37932,6707,005Sep 20 04:09 PM
Griffin Deborah AChief Accounting OfficerSep 18Sale23.712,37656,3280Sep 20 04:08 PM
Dethlefs SvenEVP Global Marketing&PortfolioSep 18Sale23.7162514,8177,265Sep 20 04:06 PM
Daniell RichardExec. VP, European CommercialSep 10Sale21.2569614,7900Sep 11 04:17 PM
Codner Iris BeckEVP Global Brand&CommunicationAug 09Sale22.704,16594,5418,290Aug 13 08:34 AM
Dethlefs SvenEVP Global Marketing&PortfolioAug 03Buy21.922,00043,8406,445Aug 07 09:45 AM